Description
Disease Indications
Psoriasis
Manufacturer
Eli Lilly Nederland B.V.
Usage
Subcutaneous
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Taltz (ixekizumab)
Price range: $1,500.00 through $3,000.00
Taltz (ixekizumab) is a medication used for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.
Additional information
| Package Prefilled syringe or autoinjector | 2 prefilled syringes or pens of 80 mg, 3 prefilled syringes or pens of 80 mg |
|---|
Related products
-
Olumiant (baricitinib)
Price range: $1,000.00 through $1,600.00 Select options This product has multiple variants. The options may be chosen on the product page -
Cibinqo (abrocitinib)
Price range: $500.00 through $1,600.00 Select options This product has multiple variants. The options may be chosen on the product page -
Skilarence (dimethyl fumarate)
Price range: $150.00 through $250.00 Select options This product has multiple variants. The options may be chosen on the product page -
Takhzyro (lanadelumab)
Price range: $9,000.00 through $40,000.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.